Home LiteratureArticle Details
PMID: 25942397 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer.

British journal of cancer ·Vol. 112 ·No. 11 ·2015-05-26 ·Pages 1782-90

Hiraoka N, Ino Y, Yamazaki-Itoh R, Kanai Y, Kosuge T, Shimada K

Abstract

Host immunity has critical roles in tumour surveillance. Tertiary lymphoid organs (TLOs) are induced in various inflamed tissues. The aim of this study was to investigate the clinicopathological and pathobiological characteristics of tumour microenvironment in pancreatic ductal carcinoma (PDC) with TLOs. We examined 534 PDCs to investigate the clinicopathological impact of TLOs and their association with tumour-infiltrating immune cells, the cytokine milieu, and tissue characteristics. There were two different localisations of PDC-associated TLOs, intratumoral and peritumoral. A better outcome was observed in patients with intratumoral TLOs, and this was independent of other survival factors. The PDC tissues with intratumoral TLOs showed significantly higher infiltration of T and B cells and lower infiltration of immunosuppressive cells, as well as significantly higher expression of Th1- and Th17-related genes. Tertiary lymphoid organs developed with an association with arterioles, venules, and nerves. These structures were reduced in an association with cancer invasion in PDC tissues, except for those with intratumoral TLOs. The PDC tissues with intratumoral TLOs had capillaries consisting of mature endothelial cells covered by pericytes. Our results suggest that the presence of intratumoral TLOs represents a microenvironment that has an active immune reaction, and shows a relatively intact vascular network retained.

MeSH Terms
Aged B-Lymphocytes Carcinoma, Pancreatic Ductal/diagnosis,immunology,pathology Female Humans Lymphocytes/immunology,pathology Lymphocytes, Tumor-Infiltrating/immunology,pathology Male Middle Aged Prognosis Tumor Microenvironment/immunology
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Hiraoka N
1] Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan [2] Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Ino Y
Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Yamazaki-Itoh R
1] Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan [2] Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Kanai Y
Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Kosuge T
Hepato-Biliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Shimada K
Hepato-Biliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo 104-0045, Japan.
References (29)
29 references, click to expand
  1. The immune contexture in human tumours: impact on clinical outcome.
    Nat Rev Cancer. 2012 Apr;12(4):298-306 PMID: 22419253
  2. Homing and cellular traffic in lymph nodes.
    Nat Rev Immunol. 2003 Nov;3(11):867-78 PMID: 14668803
  3. Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels.
    Cancer Cell. 2012 Aug 14;22(2):235-49 PMID: 22897853
  4. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes.
    Nat Rev Immunol. 2012 Nov;12(11):762-73 PMID: 23018291
  5. Innate lymphoid cells--a proposal for uniform nomenclature.
    Nat Rev Immunol. 2013 Feb;13(2):145-9 PMID: 23348417
  6. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer.
    Br J Cancer. 2013 Mar 5;108(4):914-23 PMID: 23385730
  7. Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase.
    Cell. 2001 Jun 29;105(7):957-69 PMID: 11439191
  8. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin.
    Clin Cancer Res. 2013 Aug 1;19(15):4079-91 PMID: 23785047
  9. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma.
    Pancreas. 2004 Jan;28(1):e26-31 PMID: 14707745
  10. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas.
    Nat Rev Immunol. 2004 May;4(5):360-70 PMID: 15122201
  11. A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34.
    Immunity. 1999 Jul;11(1):79-89 PMID: 10435581
  12. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
    Clin Cancer Res. 2006 Sep 15;12(18):5423-34 PMID: 17000676
  13. Ectopic lymphoid tissues and local immunity.
    Semin Immunol. 2008 Feb;20(1):26-42 PMID: 18243731
  14. Vascular normalization in Rgs5-deficient tumours promotes immune destruction.
    Nature. 2008 May 15;453(7193):410-4 PMID: 18418378
  15. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
    J Clin Oncol. 2008 Sep 20;26(27):4410-7 PMID: 18802153
  16. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications.
    Dev Cell. 2009 Feb;16(2):209-21 PMID: 19217423
  17. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
    Science. 2009 Jun 12;324(5933):1457-61 PMID: 19460966
  18. New insights into the development of lymphoid tissues.
    Nat Rev Immunol. 2010 Sep;10(9):664-74 PMID: 20706277
  19. Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer.
    J Immunol. 2010 Oct 1;185(7):4063-71 PMID: 20805420
  20. Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking.
    Cancer Sci. 2010 Nov;101(11):2302-8 PMID: 20726857
  21. CD20+ B cells: the other tumor-infiltrating lymphocytes.
    J Immunol. 2010 Nov 1;185(9):4977-82 PMID: 20962266
  22. Hallmarks of cancer: the next generation.
    Cell. 2011 Mar 4;144(5):646-74 PMID: 21376230
  23. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.
    Nat Rev Drug Discov. 2011 Jun;10(6):417-27 PMID: 21629292
  24. The development of inducible bronchus-associated lymphoid tissue depends on IL-17.
    Nat Immunol. 2011 Jul;12(7):639-46 PMID: 21666689
  25. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling.
    Am J Pathol. 2011 Jul;179(1):37-45 PMID: 21703392
  26. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.
    CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36 PMID: 21685461
  27. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.
    Cancer Res. 2011 Sep 1;71(17):5678-87 PMID: 21846823
  28. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation.
    Immunity. 2011 Dec 23;35(6):986-96 PMID: 22177922
  29. Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases.
    Cancer Res. 2012 Aug 15;72(16):3997-4007 PMID: 22850419
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
1532-1827
Published
2015-05-26
Epub
2015-00-05
Pages
1782-90
Language
English
Region
England
NLM ID
0370635
PMCID
PMC4647237
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com